{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:05Z","timestamp":1787163845779,"version":"build-2736575974"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hepatic fibrosis is a serious illness that can lead to death. Until recently, there has been no effective medication to protect the liver and heal fibrosis. When thioacetamide (TAA)-induced hepatotoxicity occurred, we aimed to determine the hepatoprotective effectiveness of adipose, bone marrow, and liver-derived mesenchymal stem cells. Fifty male albino Wistar rats were used throughout the study and divided into 5 groups. Each group had 10 rats divided into 2 cages, 5 rats per cage. Forty male albino Wistar rats were injected intraperitoneally with 100\u00a0mg\/kg of thioacetamide 2 times a week for 9\u00a0weeks. After 5\u00a0weeks of induction of liver fibrosis, forty rats were divided into four groups. One group was considered the TAA group and didn\u2019t receive any treatment, and the other three groups were inoculated with a single dose of 3\u2009\u00d7\u200910\n                    <jats:sup>6<\/jats:sup>\n                    BM-MSCs, AD-MSCs, and L-MSCs, respectively. We assessed the liver function tests as ALT, AST, and total bilirubin, which showed a significant decrease in groups inoculated with stem cells. But although the most significant decrease appeared in the L-MSCs inoculated group. Additionally, there was a notable rise in albumin levels in the L-MSC-inoculated group. In groups injected with stem cells, namely L-MSCs, the evaluation of antioxidant and oxidative stress levels revealed a substantial increase in GSH concentration, SOD activity, and CAT activity. Additionally, there is a noticeable drop in MDA and NO levels. By the ELISA technique, we assessed the hydroxyproline and collagen type-1, and the results showed a significant decrease in the groups inoculated with stem cells, especially L-MSCs. As well, this group showed a significant downregulation of ASMA gene expression. The percentage of fibrosis assessed in the histopathologic samples showed the most significant decrease in the L-MSCs inoculated group. In conclusion, our study showed that the different types of mesenchymal stem cells had an ameliorative effect on hepatic fibrosis, but the best results appeared with L-MSCs rather than BM-MSCs and AD-MSCs. The treated group with L-MSCs showed great enhancement in the antioxidant status, decreased hydroxyproline and collagen type-1 content, and a lower percentage of fibrosis.\n                  <\/jats:p>","DOI":"10.1186\/s13287-025-04707-6","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:09:15Z","timestamp":1761858555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Stem cells harvested from different sources ameliorate liver fibrosis: comparative study"],"prefix":"10.1186","volume":"16","author":[{"given":"Islam S.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeen D.","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Nabil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"4707_CR1","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.clinre.2015.06.015","volume":"39","author":"M Sun","year":"2015","unstructured":"Sun M, Kisseleva T. Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol. 2015;39:S60\u20133.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"4707_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"issue":"2","key":"4707_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/cells9020461","volume":"9","author":"S-R Ignat","year":"2020","unstructured":"Ignat S-R, et al. Cellular interplay as a consequence of inflammatory signals leading to liver fibrosis development. Cells. 2020;9(2):461.","journal-title":"Cells"},{"issue":"2","key":"4707_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115(2):209\u201318.","journal-title":"J Clin Investig"},{"issue":"47","key":"4707_CR5","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.3748\/wjg.v26.i47.7444","volume":"26","author":"Z Al-Dhamin","year":"2020","unstructured":"Al-Dhamin Z, et al. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: a systematic review of in vivo studies. World J Gastroenterol. 2020;26(47):7444.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4707_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/1566524033479528","volume":"3","author":"H Higuchi","year":"2003","unstructured":"Higuchi H, Gores GJ. Mechanisms of liver injury: an overview. Curr Mol Med. 2003;3(6):483\u201390.","journal-title":"Curr Mol Med"},{"issue":"4","key":"4707_CR7","first-page":"919","volume":"38","author":"O Vi\u00f1as","year":"2003","unstructured":"Vi\u00f1as O, et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology. 2003;38(4):919\u201329.","journal-title":"Hepatology"},{"issue":"5","key":"4707_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17(5):306\u201321.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4707_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/sji.12468","volume":"85","author":"YY Sun","year":"2017","unstructured":"Sun YY, et al. Macrophage phenotype in liver injury and repair. Scand J Immunol. 2017;85(3):166\u201374.","journal-title":"Scand J Immunol"},{"issue":"1","key":"4707_CR10","first-page":"69","volume":"8","author":"E Gabele","year":"2003","unstructured":"Gabele E, Brenner DA, Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci. 2003;8(1):69\u201377.","journal-title":"Front Biosci"},{"issue":"1","key":"4707_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0016-5085(90)91307-R","volume":"98","author":"S Milani","year":"1990","unstructured":"Milani S, et al. Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology. 1990;98(1):175\u201384.","journal-title":"Gastroenterology"},{"issue":"1","key":"4707_CR12","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4(1):2823.","journal-title":"Nat Commun"},{"issue":"6","key":"4707_CR13","first-page":"344","volume":"3","author":"R Weiskirchen","year":"2014","unstructured":"Weiskirchen R, Tacke F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary surgery and nutrition. 2014;3(6):344.","journal-title":"Hepatobiliary surgery and nutrition"},{"issue":"4","key":"4707_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/gut.46.4.443","volume":"46","author":"RC Benyon","year":"2000","unstructured":"Benyon RC, Iredale J. Is liver fibrosis reversible? Gut. 2000;46(4):443\u20136.","journal-title":"Gut"},{"issue":"3","key":"4707_CR15","doi-asserted-by":"publisher","first-page":"G471","DOI":"10.1152\/ajpgi.2000.279.3.G471","volume":"279","author":"J Lindquist","year":"2000","unstructured":"Lindquist J, Marzluff W, Stefanovic B. III. Posttranscriptional regulation of type I collagen. Am J Physiol Gastrointest Liver Physiol. 2000;279(3):G471\u20136.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"4707_CR16","doi-asserted-by":"publisher","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","volume":"279","author":"MJ Arthur","year":"2000","unstructured":"Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2000;279(2):G245\u20139.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"4707_CR17","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1073\/pnas.0409722102","volume":"102","author":"JS Campbell","year":"2005","unstructured":"Campbell JS, et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA. 2005;102(9):3389\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"4707_CR18","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","volume":"16","author":"HZ Ying","year":"2017","unstructured":"Ying HZ, et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics. Mol Med Rep. 2017;16(6):7879\u201389.","journal-title":"Mol Med Rep"},{"key":"4707_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fphar.2016.00481","volume":"7","author":"S Ghosh","year":"2016","unstructured":"Ghosh S, et al. Silymarin protects mouse liver and kidney from thioacetamide induced toxicity by scavenging reactive oxygen species and activating PI3K-Akt pathway. Front Pharmacol. 2016;7:481.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4707_CR20","doi-asserted-by":"publisher","first-page":"102531","DOI":"10.1016\/j.jksus.2022.102531","volume":"35","author":"H Ebaid","year":"2023","unstructured":"Ebaid H, et al. Protective effect of gallic acid against thioacetamide-induced metabolic dysfunction of lipids in hepatic and renal toxicity. J King Saud Univ Sci. 2023;35(3):102531.","journal-title":"J King Saud Univ Sci"},{"issue":"16","key":"4707_CR21","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1039\/D1AN00862E","volume":"146","author":"SA Kitte","year":"2021","unstructured":"Kitte SA, et al. Electrochemiluminescence of Ru (bpy) 3 2+\/thioacetamide and its application for the sensitive determination of hepatotoxic thioacetamide. Analyst. 2021;146(16):5198\u2013203.","journal-title":"Analyst"},{"key":"4707_CR22","doi-asserted-by":"publisher","first-page":"109098","DOI":"10.1016\/j.cbi.2020.109098","volume":"324","author":"RM Hussein","year":"2020","unstructured":"Hussein RM, et al. Gallic acid and ferulic acid protect the liver from thioacetamide-induced fibrosis in rats via differential expression of miR-21, miR-30 and miR-200 and impact on TGF-\u03b21\/Smad3 signaling. Chem Biol Interact. 2020;324:109098.","journal-title":"Chem Biol Interact"},{"issue":"12","key":"4707_CR23","doi-asserted-by":"publisher","first-page":"e0260130","DOI":"10.1371\/journal.pone.0260130","volume":"16","author":"RF Abdel-Rahman","year":"2021","unstructured":"Abdel-Rahman RF, et al. The involvement of TGF-\u03b21\/FAK\/\u03b1-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats. PLoS ONE. 2021;16(12):e0260130.","journal-title":"PLoS ONE"},{"issue":"5","key":"4707_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrgastro.2014.44","volume":"11","author":"SJ Forbes","year":"2014","unstructured":"Forbes SJ, Alison MR. Knocking on the door to successful hepatocyte transplantation. Nat Rev Gastroenterol Hepatol. 2014;11(5):277\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4707_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s13770-019-00178-y","volume":"16","author":"J Wang","year":"2019","unstructured":"Wang J, et al. Stem cell-based therapies for liver diseases: an overview and update. Tissue Eng Regen Med. 2019;16:107\u201318.","journal-title":"Tissue Eng Regen Med"},{"issue":"43","key":"4707_CR26","doi-asserted-by":"publisher","first-page":"12334","DOI":"10.3748\/wjg.v21.i43.12334","volume":"21","author":"E Tsolaki","year":"2015","unstructured":"Tsolaki E, Yannaki E. Stem cell-based regenerative opportunities for the liver: State of the art and beyond. World J Gastroenterol. 2015;21(43):12334.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4707_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/scd.2016.0218","volume":"26","author":"A Assoni","year":"2017","unstructured":"Assoni A, et al. Different donors mesenchymal stromal cells secretomes reveal heterogeneous profile of relevance for therapeutic use. Stem cells Dev. 2017;26(3):206\u201314.","journal-title":"Stem cells Dev"},{"issue":"7","key":"4707_CR28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.21037\/atm.2017.03.50","volume":"5","author":"L Beer","year":"2017","unstructured":"Beer L, Mildner M, Ankersmit HJ. Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science. Ann Transl Med. 2017;5(7):170.","journal-title":"Ann Transl Med"},{"issue":"27","key":"4707_CR29","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.2174\/0929867323666160627112827","volume":"23","author":"A Fierabracci","year":"2016","unstructured":"Fierabracci A, Fattore AD, Muraca M. The immunoregulatory activity of mesenchymal stem cells:\u2018state of art\u2019and \u2018future avenues.\u2019 Curr Med Chem. 2016;23(27):3014\u201324.","journal-title":"Curr Med Chem"},{"issue":"8","key":"4707_CR30","doi-asserted-by":"publisher","first-page":"1500393","DOI":"10.1002\/advs.201500393","volume":"3","author":"M Wang","year":"2016","unstructured":"Wang M, et al. Sustained delivery growth factors with polyethyleneimine-modified nanoparticles promote embryonic stem cells differentiation and liver regeneration. Adv Sci. 2016;3(8):1500393.","journal-title":"Adv Sci"},{"issue":"6","key":"4707_CR31","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/jcb.22091","volume":"106","author":"ZJ Liu","year":"2009","unstructured":"Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106(6):984\u201391.","journal-title":"J Cell Biochem"},{"key":"4707_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ymeth.2015.09.016","volume":"99","author":"J Kobolak","year":"2016","unstructured":"Kobolak J, et al. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods. 2016;99:62\u20138.","journal-title":"Methods"},{"issue":"8","key":"4707_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ncb3203","volume":"17","author":"W-Y Lu","year":"2015","unstructured":"Lu W-Y, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol. 2015;17(8):971\u201383.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"4707_CR34","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1089\/ten.tec.2009.0795","volume":"16","author":"A Carraro","year":"2010","unstructured":"Carraro A, et al. A combining method to enhance the in vitro differentiation of hepatic precursor cells. Tissue Eng Part C Methods. 2010;16(6):1543\u201351.","journal-title":"Tissue Eng Part C Methods"},{"issue":"4","key":"4707_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.21608\/zvjz.2017.7866","volume":"45","author":"MF Dowidar","year":"2017","unstructured":"Dowidar MF, et al. Biochemical and molecular studies on bone marrow derived stromal stem cells on liver injuries in rats. Zagazig Vet J. 2017;45(4):355\u201365.","journal-title":"Zagazig Vet J"},{"key":"4707_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s12072-014-9599-4","volume":"9","author":"SK Lee","year":"2015","unstructured":"Lee SK, Lee SC, Kim S-J. A novel cell-free strategy for promoting mouse liver regeneration: utilization of a conditioned medium from adipose-derived stem cells. Hep Intl. 2015;9:310\u201320.","journal-title":"Hep Intl"},{"issue":"3","key":"4707_CR37","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3892\/mmr.2014.2935","volume":"11","author":"L Yin","year":"2015","unstructured":"Yin L, et al. Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro. Mol Med Rep. 2015;11(3):1722\u201332.","journal-title":"Mol Med Rep"},{"issue":"12","key":"4707_CR38","doi-asserted-by":"publisher","first-page":"15881","DOI":"10.3390\/ijms131215881","volume":"13","author":"B Galateanu","year":"2012","unstructured":"Galateanu B, et al. Modulation of adipogenic conditions for prospective use of hADSCs in adipose tissue engineering. Int J Mol Sci. 2012;13(12):15881\u2013900.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4707_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5009\/gnl18412","volume":"14","author":"SH Kang","year":"2019","unstructured":"Kang SH, et al. Mesenchymal stem cells for the treatment of liver disease: present and perspectives. Gut Liver. 2019;14(3):306.","journal-title":"Gut Liver"},{"key":"4707_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer E, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front Immunol. 2012;3:297.","journal-title":"Front Immunol"},{"key":"4707_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01895-1","volume":"11","author":"C Hu","year":"2020","unstructured":"Hu C, et al. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020;11:1\u201312.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4707_CR42","first-page":"6546780","volume":"2021","author":"M Zhu","year":"2021","unstructured":"Zhu M, et al. Applications of mesenchymal stem cells in liver fibrosis: novel strategies, mechanisms, and clinical practice. Stem Cells Int. 2021;2021(1):6546780.","journal-title":"Stem Cells Int"},{"issue":"3","key":"4707_CR43","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/hep.25722","volume":"56","author":"J Li","year":"2012","unstructured":"Li J, et al. Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. Hepatology. 2012;56(3):1044\u201352.","journal-title":"Hepatology"},{"issue":"2","key":"4707_CR44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.26670","volume":"59","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, et al. Mesenchymal stem cells alleviate bacteria-induced liver injury in mice by inducing regulatory dendritic cells. Hepatology. 2014;59(2):671\u201382.","journal-title":"Hepatology"},{"issue":"6","key":"4707_CR45","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jhep.2015.07.035","volume":"63","author":"K-C Lee","year":"2015","unstructured":"Lee K-C, et al. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease. J Hepatol. 2015;63(6):1405\u201312.","journal-title":"J Hepatol"},{"issue":"6","key":"4707_CR46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1042\/CBI20090386","volume":"34","author":"V Rabani","year":"2010","unstructured":"Rabani V, et al. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Cell Biol Int. 2010;34(6):601\u20135.","journal-title":"Cell Biol Int"},{"issue":"13\u201314","key":"4707_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.lfs.2009.08.003","volume":"85","author":"Y-J Chang","year":"2009","unstructured":"Chang Y-J, et al. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci. 2009;85(13\u201314):517\u201325.","journal-title":"Life Sci"},{"issue":"10","key":"4707_CR48","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","volume":"24","author":"S Terai","year":"2006","unstructured":"Terai S, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells (Dayton, Ohio). 2006;24(10):2292\u20138.","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"10","key":"4707_CR49","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","volume":"21","author":"P Kharaziha","year":"2009","unstructured":"Kharaziha P, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;21(10):1199\u2013205.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"4707_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.29189","volume":"66","author":"BL Lin","year":"2017","unstructured":"Lin BL, et al. Allogeneic bone marrow\u2013derived mesenchymal stromal cells for hepatitis B virus\u2013related acute-on-chronic liver failure: a randomized controlled trial. Hepatology. 2017;66(1):209\u201319.","journal-title":"Hepatology"},{"issue":"3","key":"4707_CR51","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/hep.24434","volume":"54","author":"L Peng","year":"2011","unstructured":"Peng L, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology. 2011;54(3):820\u20138.","journal-title":"Hepatology"},{"issue":"6","key":"4707_CR52","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.28693","volume":"64","author":"KT Suk","year":"2016","unstructured":"Suk KT, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial. Hepatology. 2016;64(6):2185\u201397.","journal-title":"Hepatology"},{"issue":"1","key":"4707_CR53","first-page":"26","volume":"3","author":"S Huang","year":"2015","unstructured":"Huang S, et al. An improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. J Orthop Transl. 2015;3(1):26\u201333.","journal-title":"J Orthop Transl"},{"issue":"3","key":"4707_CR54","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nprot.2010.199","volume":"6","author":"S Sugii","year":"2011","unstructured":"Sugii S, et al. Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc. 2011;6(3):346\u201358.","journal-title":"Nat Protoc"},{"key":"4707_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-61779-468-1_3","volume":"826","author":"M Tanaka","year":"2012","unstructured":"Tanaka M, Miyajima A. Identification and isolation of adult liver stem\/progenitor cells. Methods Mol Biol. 2012;826:25\u201332.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"4707_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/biom14030297","volume":"14","author":"A Elzainy","year":"2024","unstructured":"Elzainy A, El Sadik A, Altowayan WM. Comparison between the regenerative and therapeutic impacts of bone marrow mesenchymal stem cells and adipose mesenchymal stem cells pre-treated with melatonin on liver fibrosis. Biomolecules. 2024;14(3):297.","journal-title":"Biomolecules"},{"issue":"11","key":"4707_CR57","first-page":"879","volume":"17","author":"D Qin","year":"2014","unstructured":"Qin D, Nie Y, Wen Z. Protection of rats from thioacetamide-induced hepatic fibrosis by the extracts of a traditional Uighur medicine Cichorium glandulosum. Iran J Basic Med Sci. 2014;17(11):879.","journal-title":"Iran J Basic Med Sci"},{"issue":"22","key":"4707_CR58","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.3748\/wjg.v11.i22.3431","volume":"11","author":"D-C Zhao","year":"2005","unstructured":"Zhao D-C, et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol. 2005;11(22):3431.","journal-title":"World J Gastroenterol"},{"key":"4707_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1474-8","volume":"10","author":"S Yu","year":"2019","unstructured":"Yu S, et al. Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats. Stem Cell Res Ther. 2019;10:1\u201318.","journal-title":"Stem Cell Res Ther"},{"issue":"30","key":"4707_CR60","doi-asserted-by":"publisher","first-page":"10553","DOI":"10.3748\/wjg.v20.i30.10553","volume":"20","author":"C Maerckx","year":"2014","unstructured":"Maerckx C, et al. Human liver stem\/progenitor cells decrease serum bilirubin in hyperbilirubinemic Gunn rat. World J Gastroenterol. 2014;20(30):10553.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4707_CR61","first-page":"212","volume":"8","author":"CF Brito","year":"2020","unstructured":"Brito CF, et al. Laboratory mice euthanasia: speed death and animal welfare. Am J Biomed Sci Res. 2020;8(4):212\u20135.","journal-title":"Am J Biomed Sci Res"},{"issue":"5","key":"4707_CR62","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/clinchem\/23.5.887","volume":"23","author":"HU Bergmeyer","year":"1977","unstructured":"Bergmeyer HU, et al. Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Clin Chem. 1977;23(5):887\u201399.","journal-title":"Clin Chem"},{"key":"4707_CR63","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0021-9258(18)74392-5","volume":"119","author":"HT Malloy","year":"1937","unstructured":"Malloy HT, Evelyn KA. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem. 1937;119:481\u201390.","journal-title":"J Biol Chem"},{"issue":"1","key":"4707_CR64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0009-8981(71)90365-2","volume":"31","author":"BT Doumas","year":"1971","unstructured":"Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta Int J Clin Chem. 1971;31(1):87\u201396.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"1","key":"4707_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/niox.2000.0319","volume":"5","author":"KM Miranda","year":"2001","unstructured":"Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide Biol Chem. 2001;5(1):62\u201371.","journal-title":"Nitric Oxide Biol Chem"},{"issue":"10","key":"4707_CR66","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1021\/tx9701790","volume":"11","author":"D G\u00e9rard-Monnier","year":"1998","unstructured":"G\u00e9rard-Monnier D, et al. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol. 1998;11(10):1176\u201383.","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"4707_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00216-006-0375-8","volume":"385","author":"IH Shaik","year":"2006","unstructured":"Shaik IH, Mehvar R. Rapid determination of reduced and oxidized glutathione levels using a new thiol-masking reagent and the enzymatic recycling method: application to the rat liver and bile samples. Anal Bioanal Chem. 2006;385(1):105\u201313.","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"4707_CR68","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0003-2697(88)90554-4","volume":"174","author":"LH Johansson","year":"1988","unstructured":"Johansson LH, Borg LA. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem. 1988;174(1):331\u20136.","journal-title":"Anal Biochem"},{"issue":"3","key":"4707_CR69","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47(3):469\u201374.","journal-title":"Eur J Biochem"},{"issue":"7","key":"4707_CR70","first-page":"616","volume":"16","author":"D Leeming","year":"2011","unstructured":"Leeming D, et al. A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomark Biochem Indic Expo Response, Susceptibility Chem. 2011;16(7):616\u201328.","journal-title":"Biomark Biochem Indic Expo Response, Susceptibility Chem"},{"key":"4707_CR71","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0003-2697(60)90050-6","volume":"1","author":"DJ Prockop","year":"1960","unstructured":"Prockop DJ, Udenfriend S. A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem. 1960;1:228\u201339.","journal-title":"Anal Biochem"},{"issue":"10","key":"4707_CR72","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1590\/1414-431X20143679","volume":"47","author":"JO Gon\u00e7alves","year":"2014","unstructured":"Gon\u00e7alves JO, et al. Dynamic expression of desmin, \u03b1-SMA and TGF-\u03b21 during hepatic fibrogenesis induced by selective bile duct ligation in young rats. Braz J Med Biol Res. 2014;47(10):850\u20137.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"4707_CR73","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1038\/mtna.2015.49","volume":"5","author":"H Abe","year":"2016","unstructured":"Abe H, et al. Effective prevention of liver fibrosis by liver-targeted hydrodynamic gene delivery of matrix metalloproteinase-13 in a rat liver fibrosis model. Mol Ther Nucleic Acids. 2016;5(1):e276.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"4707_CR74","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.3390\/app13095243","volume":"13","author":"SH Shareef","year":"2023","unstructured":"Shareef SH, et al. Hepatoprotective EFFECT OF ALPINETIN ON THIOACETAMIDE-INDUCED LIVER FIBROSIS IN SPRAGUE DAWLEY RAT. Appl Sci. 2023;13(9):5243.","journal-title":"Appl Sci"},{"issue":"9","key":"4707_CR75","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/lt.21845","volume":"15","author":"F Liu","year":"2009","unstructured":"Liu F, et al. Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transpl. 2009;15(9):1092\u2013100.","journal-title":"Liver Transpl"},{"issue":"6","key":"4707_CR76","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3109\/14653249.2011.583476","volume":"13","author":"V Sordi","year":"2011","unstructured":"Sordi V, Piemonti L. Therapeutic plasticity of stem cells and allograft tolerance. Cytotherapy. 2011;13(6):647\u201360.","journal-title":"Cytotherapy"},{"issue":"2","key":"4707_CR77","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00441-008-0724-3","volume":"335","author":"X Fu","year":"2009","unstructured":"Fu X, Li H. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions. Cell Tissue Res. 2009;335(2):317\u201321.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"4707_CR78","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semnephrol.2006.09.013","volume":"27","author":"CA Dinarello","year":"2007","unstructured":"Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol. 2007;27(1):98\u2013114.","journal-title":"Semin Nephrol"},{"key":"4707_CR79","doi-asserted-by":"publisher","first-page":"560345","DOI":"10.1155\/2012\/560345","volume":"2012","author":"L Li","year":"2012","unstructured":"Li L, et al. Establishment of a standardized liver fibrosis model with different pathological stages in rats. Gastroenterol Res Pract. 2012;2012:560345.","journal-title":"Gastroenterol Res Pract"},{"issue":"7","key":"4707_CR80","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cellbi.2009.04.023","volume":"33","author":"KA Cho","year":"2009","unstructured":"Cho KA, et al. Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol Int. 2009;33(7):772\u20137.","journal-title":"Cell Biol Int"},{"issue":"5","key":"4707_CR81","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bj.2020.04.011","volume":"44","author":"MR Khalil","year":"2021","unstructured":"Khalil MR, et al. Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis. Biomed J. 2021;44(5):598\u2013610.","journal-title":"Biomed J"},{"key":"4707_CR82","doi-asserted-by":"publisher","first-page":"6574010","DOI":"10.1155\/2020\/6574010","volume":"2020","author":"G Shiha","year":"2020","unstructured":"Shiha G, et al. Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl(4)-Induced Liver Fibrosis. Stem Cells Int. 2020;2020:6574010.","journal-title":"Stem Cells Int"},{"issue":"1","key":"4707_CR83","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2007.01.015","volume":"560","author":"G Wang","year":"2007","unstructured":"Wang G, et al. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Eur J Pharmacol. 2007;560(1):61\u20138.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4707_CR84","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3748\/wjg.v21.i3.742","volume":"21","author":"S Berardis","year":"2015","unstructured":"Berardis S, et al. Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects. World J Gastroenterol. 2015;21(3):742\u201358.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4707_CR85","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.intimp.2010.01.014","volume":"10","author":"S Pulavendran","year":"2010","unstructured":"Pulavendran S, Vignesh J, Rose C. Differential anti-inflammatory and anti-fibrotic activity of transplanted mesenchymal vs. hematopoietic stem cells in carbon tetrachloride-induced liver injury in mice. Int Immunopharmacol. 2010;10(4):513\u20139.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"4707_CR86","first-page":"128","volume":"8","author":"HG Sayyed","year":"2016","unstructured":"Sayyed HG, et al. Comparison of the therapeutic effectiveness of human CD34(+) and rat bone marrow mesenchymal stem cells on improvement of experimental liver fibrosis in Wistar rats. Int J Physiol Pathophysiol Pharmacol. 2016;8(3):128\u201339.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"4707_CR87","doi-asserted-by":"publisher","first-page":"762196","DOI":"10.1155\/2013\/762196","volume":"2013","author":"P Prasajak","year":"2013","unstructured":"Prasajak P, Leeanansaksiri W. Developing a new two-step protocol to generate functional hepatocytes from Wharton\u2019s jelly-derived mesenchymal stem cells under hypoxic condition. Stem Cells Int. 2013;2013:762196.","journal-title":"Stem Cells Int"},{"issue":"25","key":"4707_CR88","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","volume":"328","author":"SL Friedman","year":"1993","unstructured":"Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. New Engl J Med. 1993;328(25):1828\u201335.","journal-title":"New Engl J Med"},{"key":"4707_CR89","doi-asserted-by":"publisher","first-page":"6678913","DOI":"10.1155\/2021\/6678913","volume":"2021","author":"A Nabil","year":"2021","unstructured":"Nabil A, et al. The potential safe antifibrotic effect of stem cell conditioned medium and nilotinib combined therapy by selective elimination of rat activated HSCs. Biomed Res Int. 2021;2021:6678913.","journal-title":"Biomed Res Int"},{"issue":"3","key":"4707_CR90","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2014.10.030","volume":"62","author":"RP Meier","year":"2015","unstructured":"Meier RP, et al. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J Hepatol. 2015;62(3):634\u201341.","journal-title":"J Hepatol"},{"issue":"10","key":"4707_CR91","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3748\/wjg.v18.i10.1048","volume":"18","author":"W Zhao","year":"2012","unstructured":"Zhao W, et al. Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol. 2012;18(10):1048\u201358.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4707_CR92","first-page":"107","volume":"8","author":"Y Cai","year":"2015","unstructured":"Cai Y, et al. Bone marrow-derived mesenchymal stem cells inhibits hepatocyte apoptosis after acute liver injury. Int J Clin Exp Pathol. 2015;8(1):107\u201316.","journal-title":"Int J Clin Exp Pathol"},{"key":"4707_CR93","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41232-019-0107-z","volume":"39","author":"A Tsuchiya","year":"2019","unstructured":"Tsuchiya A, et al. Mesenchymal stem cell therapies for liver cirrhosis: MSCs as \u201cconducting cells\u201d for improvement of liver fibrosis and regeneration. Inflamm Regen. 2019;39:18.","journal-title":"Inflamm Regen"},{"issue":"3","key":"4707_CR94","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/sctm.18-0105","volume":"8","author":"Y Watanabe","year":"2019","unstructured":"Watanabe Y, et al. Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice. Stem Cells Transl Med. 2019;8(3):271\u201384.","journal-title":"Stem Cells Transl Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04707-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04707-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04707-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:02:33Z","timestamp":1761861753000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04707-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4707"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04707-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The entire experimental protocol was approved by Mansoura University's Animal Care and Use Committee (MU-ACUC), and the study was registered at the Faculty of Veterinary Medicine, Mansoura University, Egypt. Title of the approved project: \u201cStem Cells Harvested from Different Sources Ameliorate Liver Fibrosis: Comparative Study\u201d with approval number: MU-ACUC (VM.R.24.11.192). Date of approval: 7 November 2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"598"}}